Reply to Zhou and Wu, "be careful with adverse events caused by cefoperazone-sulbactam"

Jien Wei Liu, Yen Hsu Chen, Wen Sen Lee, Jung Chung Lin, Ching Tai Huang, Hsi Hsun Lin, Yung Ching Liu, Yin Ching Chuang, Hung Jen Tang, Yao Shen Chen, Wen Chien Ko, Min Chi Lu, Fu Der Wangn

研究成果: Letter同行評審

原文English
文章編號e02028
期刊Antimicrobial agents and chemotherapy
64
發行號2
DOIs
出版狀態Published - 2020 一月 27

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

引用此